French researchers (French Blood Agency, EDS, CNRS, and University of Mediterranée) succeeded, by gene transfer, in modifying genetically a blood group (the Kidd/JK group). To do so, they used cord blood stem cells cultivated in vitro until obtaining erythrocytes.
To the long-term, this technique could be used to produce rare blood group.
